Health Sector Payment Transparency Act, 2017 - New Regulation
Published on March 12, 2018Author: Bhavesh Patel
The Ministry of Health and Long-Term Care for the Province of Ontario recently published draft Regulations for the recently enacted Health Sector Payment Transparency Act, 2017 (“HSPTA”). The HSPTA is intended to strengthen transparency in the financial relationships that exist within Ontario's health care system for the ultimate purpose of increasing public trust and confidence.
To achieve its intended purpose, the HSPTA creates various reporting requirements that apply to transactions within the context of certain relationships within the health care system. The HSPTA also mandates analysis and publication of the information.
One of the main reporting requirements pertains to pharmaceutical and medical device companies where there is a “transfer of value” between them and the health care provider. While much of the terminology is undefined in the HSPTA, the recently published Regulations provide greater clarify, for example, the Regulations:
The Ministry is requesting feedback on this regulatory proposal. The draft Regulations are available for public consultation until April 5, 2018.
Thank you for reading Regulated Affairs, the CAPRA Blog. CAPRA is a non-profit organization dedicated to providing professional development opportunities in Regulatory Affairs. Feel free to share our blog posts and join us on social media.
Reference:
Related Articles
Rare Diseases and Orphan Drugs Regulatory Framework in Canada: Recent Initiatives by Government of Canada
What are Rare Diseases and How do They Affect Canadians? According to Health Canada, rare diseases are life-threatening, debilitating, or serious and chronic conditions that...
Health Canada changes filing requirements for product monographs
Did you know, effective immediately, Health Canada is changing the submission requirements for second language product monographs for human drugs? This is for only post-life...
Pragmatic Clinical Trials: Testing Treatments in the Real-World
What is a Pragmatic Clinical Trial? Clinical trials can be designed to be either pragmatic or explanatory. Explanatory trials are designed to find out whether a treatment...